These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26405798)

  • 21. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
    Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
    PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.
    Jiang WM; Wang SC; Liu HL; Yu JM; Du X; Hou GY; Li JP; Liu S; Wang KC; Zhuang QY; Liu XM; Chen JM
    Vaccine; 2014 Nov; 32(48):6433-9. PubMed ID: 25285880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
    Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.
    Liu L; Li Z; Zhou J; Lu J; Li X; Liu J; Xiao N; Wang D
    Virus Genes; 2021 Apr; 57(2):164-171. PubMed ID: 33606171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
    Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
    Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
    Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
    Yang X; Zhao J; Wang C; Duan Y; Zhao Z; Chen R; Zhang L; Xing L; Lai C; Zhang S; Wang X; Yang P
    PLoS One; 2015; 10(4):e0123659. PubMed ID: 25884801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
    de Jonge J; Isakova-Sivak I; van Dijken H; Spijkers S; Mouthaan J; de Jong R; Smolonogina T; Roholl P; Rudenko L
    Mol Ther; 2016 May; 24(5):991-1002. PubMed ID: 26796670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
    Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
    Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
    Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.
    Ou H; Yao W; Wu N; Wang FX; Weng T; Han C; Lu X; Yu D; Wu H; Cheng L; Chen H; Yao H; Li L
    Oncotarget; 2016 Dec; 7(49):81012-81025. PubMed ID: 27768591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method.
    Long Y; Ma L; Liu Z; Song S; Geng X; Yang F; Guo Q; Li Z; Li W; Liao G
    Hum Vaccin Immunother; 2018 Mar; 14(3):615-622. PubMed ID: 29064728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.
    Carter DM; Bloom CE; Kirchenbaum GA; Tsvetnitsky V; Isakova-Sivak I; Rudenko L; Ross TM
    Vaccine; 2015 Jan; 33(1):108-16. PubMed ID: 25448100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets.
    Chen Z; Santos C; Aspelund A; Gillim-Ross L; Jin H; Kemble G; Subbarao K
    J Virol; 2009 Jan; 83(1):65-72. PubMed ID: 18945773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M; de Jonge J; Laue M; Wolff T
    Vaccine; 2011 Jul; 29(32):5153-62. PubMed ID: 21624413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.